WellPoint and its affiliated health plans (WellPoint) have distributed pill boxes at no extra cost to more than 187,000 at-risk members of Medicare Advantage and Prescription Drug plans across the country as a friendly reminder for them to take their medicines.
WellPoint and its affiliated health plans (WellPoint) have distributed pill boxes at no extra cost to more than 187,000 at-risk members of Medicare Advantage and Prescription Drug plans across the country as a friendly reminder for them to take their medicines.
“WellPoint developed this program to educate members of its affiliated plans on the importance of taking their medications,” WellPoint spokesperson Doug Bennett Jr, said. “The pill box was provided as a tool and an educational piece was provided on the importance of compliance to drug regimens.”
Members on long-term medications in Medicare Advantage and Prescription Drug Plans were stratified through claims data, and those at-risk of non-compliance were sent a pill box through the mail. The clear boxes are designed to hold a week of medication, including vitamins and over-the-counter drugs. The boxes help members keep their pills organized, and remind them when a dose is due or missed and when refills are needed.
According to Bennett, distribution costs for the pill boxes were relatively low, but he could not disclose the exact pricing.
According to one study, people with chronic diseases typically take only 50% of doses prescribed by their doctors, costing the system more than $100 billion annually, due primarily to hospitalizations that otherwise could have been avoided.
“The primary goal is to help members stay healthy by staying on their prescribed drug regimen,” Bennett said. “Ideally, this also would result in fewer acute conditions for our members, and may also help decrease hospital admissions and costs. For example, if members adhere more closely to their blood pressure medicine, they may be able to reduce their risk for other cardiovascular concerns. We are also eager to improve member satisfaction and raise our CMS clinical Star scores.”
“WellPoint continues to explore programs to encourage compliance to their prescribed regimens as well as get recommended health screenings,” Bennett said. “For example, we send all Medicare Advantage members a personalized Healthy Checklist that encourages them to talk with their doctor about preventive screenings and services they may need, as well as to see their doctors for an annual wellness visit and other health concerns.”
The Healthy Checklist also encourages members with chronic conditions to take medication as directed and to work with their doctor to manage their condition.
FDA Approves Two More Denosumab Biosimilars, Conexxence and Bomyntra
March 27th 2025The fourth pair of denosumab biosimilars, Conexxence and Bomyntra, are expected to launch in the United States in mid 2025, as a result of a global settlement with Amgen, according to a company news release.
Read More
FDA Approves First Drug for Excess Hunger in Prader-Willi Syndrome
March 27th 2025Vykat XR will be available in April to treat the intense hunger that is a hallmark of the rare genetic disease Prader-Willi syndrome. The price is based on a patient’s weight, and the average patient in the clinical trials would have had an average annual cost of $466,200 for the first year.
Read More
FDA Approves Amvuttra for ATTR-CM in Extended Label
March 21st 2025This expanded indication for Amvuttra makes it the first and only FDA-approved treatment for transthyretin amyloidosis with cardiomyopathy (ATTR-CM) and the polyneuropathy of hereditary transthyretin-mediated amyloidosis (hATTR-PN) in adults.
Read More